<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://fazen.markets/zh/eca-marcellus信托0-021美元分派</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:48:07.665Z</news:publication_date>
      <news:title>ECA Marcellus Trust I 宣布每单位0.021美元季度分派</news:title>
      <news:keywords>eca-marcellus-trust-i, royalty-trust, natural-gas-distribution, ectm, marcellus-shale</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/eca-marcellus-trust-i-distribucion-trimestral-0021-dolares</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:48:07.665Z</news:publication_date>
      <news:title>ECA Marcellus Trust I declara distribución trimestral de $0,021</news:title>
      <news:keywords>eca-marcellus-trust-i, royalty-trust, natural-gas-distribution, ectm, marcellus-shale</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/eca-marcellus-trust-i-distribution-trimestrielle-0021</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:48:07.664Z</news:publication_date>
      <news:title>ECA Marcellus Trust I déclare une distribution trimestrielle de 0,021 $</news:title>
      <news:keywords>eca-marcellus-trust-i, royalty-trust, natural-gas-distribution, ectm, marcellus-shale</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/eca-marcellus-trust-i-declares-0-021-quarterly-distribution</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:48:07.663Z</news:publication_date>
      <news:title>ECA Marcellus Trust I Declares $0.021 Quarterly Distribution</news:title>
      <news:keywords>eca-marcellus-trust-i, royalty-trust, natural-gas-distribution, ectm, marcellus-shale</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/eca-marcellus-trust-i-distribuzione-trimestrale-0021-dollari</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:48:07.663Z</news:publication_date>
      <news:title>ECA Marcellus Trust I dichiara distribuzione trimestrale di $0,021</news:title>
      <news:keywords>eca-marcellus-trust-i, royalty-trust, natural-gas-distribution, ectm, marcellus-shale</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/aevex-ricavi-crescono-56-5-ma-perdita-fiscale-16-8-milioni</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:42:08.062Z</news:publication_date>
      <news:title>Ricavi AEVEX +56,5% ma l&apos;onere fiscale porta a perdita di 16,8 mln</news:title>
      <news:keywords>aevex-corp, avex-stock, q3-2026-earnings, defense-technology, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/aevex营收增56-5-税项致亏</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:42:08.062Z</news:publication_date>
      <news:title>AEVEX营收飙升56.5% 但税项拖累转为1680万美元亏损</news:title>
      <news:keywords>aevex-corp, avex-stock, q3-2026-earnings, defense-technology, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/aevex-ingresos-suben-56-5-cargo-fiscal-perdidas-16-8-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:42:08.062Z</news:publication_date>
      <news:title>AEVEX eleva ingresos 56,5% pero el cargo fiscal le genera pérdidas de 16,8 M$</news:title>
      <news:keywords>aevex-corp, avex-stock, q3-2026-earnings, defense-technology, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/aevex-chiffre-affaires-hausse-perte-nette-charge-fiscale</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:42:08.062Z</news:publication_date>
      <news:title>AEVEX : chiffre d&apos;affaires +56,5 %, mais une perte nette de 16,8 M$</news:title>
      <news:keywords>aevex-corp, avex-stock, q3-2026-earnings, defense-technology, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/aevex-q3-2026-revenue-jumps-56-percent-net-loss-tax-charge</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:42:08.061Z</news:publication_date>
      <news:title>AEVEX Revenue Jumps 56.5% But Tax Charge Swings to $16.8M Loss</news:title>
      <news:keywords>aevex-corp, avex-stock, q3-2026-earnings, defense-technology, adjusted-ebitda</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/mp-materials-sube-insiders-compran-3-35-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:36:02.677Z</news:publication_date>
      <news:title>MP Materials sube 5,5% tras compras de insiders por 3,35M$</news:title>
      <news:keywords>mp-materials, insider-buying, rare-earth-stocks, critical-minerals, nyse-mp</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/mp材料内部人士买入大涨</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:36:02.677Z</news:publication_date>
      <news:title>MP Materials因内部人士购入335万美元大涨5.5%</news:title>
      <news:keywords>mp-materials, insider-buying, rare-earth-stocks, critical-minerals, nyse-mp</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/mp-materials-bondit-5-5-apres-achats-inities-3-35-m</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:36:02.677Z</news:publication_date>
      <news:title>MP Materials bondit de 5,5% après des achats d&apos;initiés de 3,35 M$</news:title>
      <news:keywords>mp-materials, insider-buying, rare-earth-stocks, critical-minerals, nyse-mp</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/mp-materials-sale-5-5-acquisti-insider-3-35-milioni</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:36:02.673Z</news:publication_date>
      <news:title>MP Materials sale del 5,5% con acquisti insider da 3,35 mln</news:title>
      <news:keywords>mp-materials, insider-buying, rare-earth-stocks, critical-minerals, nyse-mp</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/mp-materials-stock-jumps-insider-buying-rare-earth-magnets</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:36:02.673Z</news:publication_date>
      <news:title>MP Materials Jumps 5.5% as Insiders Buy $3.35M</news:title>
      <news:keywords>mp-materials, insider-buying, rare-earth-stocks, critical-minerals, nyse-mp</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/datameds-ai-ricavi-q3-2026-crescita-sequenziale-utile-debito</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:35:07.103Z</news:publication_date>
      <news:title>DataMEDS AI: ricavi Q3 +50% sequenziale, utile netto 10,5 M$</news:title>
      <news:keywords>datameds-ai, meds-stock, glp-1-pharmacy, healthcare-earnings, nasdaq-compliance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/datameds-ai-meds-第三季度财报</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:35:07.103Z</news:publication_date>
      <news:title>DataMEDS AI第三季度营收环比激增50%，净利润1050万美元</news:title>
      <news:keywords>datameds-ai, meds-stock, glp-1-pharmacy, healthcare-earnings, nasdaq-compliance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/datameds-ai-ingresos-q3-suben-50-beneficio-neto-10-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:35:07.103Z</news:publication_date>
      <news:title>DataMEDS AI: ingresos Q3 suben 50% secuencial, beneficio neto 10,5 M$</news:title>
      <news:keywords>datameds-ai, meds-stock, glp-1-pharmacy, healthcare-earnings, nasdaq-compliance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/datameds-ai-benefice-t3-extinction-dette-pivot-glp1</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:35:07.103Z</news:publication_date>
      <news:title>DataMEDS AI : chiffre d&apos;affaires T3 en hausse de 50 %, bénéfice net de 10,5 M$</news:title>
      <news:keywords>datameds-ai, meds-stock, glp-1-pharmacy, healthcare-earnings, nasdaq-compliance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/datameds-ai-q3-2026-revenue-jumps-50-percent-net-profit</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:35:07.101Z</news:publication_date>
      <news:title>DataMEDS AI Q3 Revenue Jumps 50% Sequential, Net Profit $10.5M</news:title>
      <news:keywords>datameds-ai, meds-stock, glp-1-pharmacy, healthcare-earnings, nasdaq-compliance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/fiee-ingresos-382-por-ciento-9-6-millones-beneficio-neto-positivo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:34:04.213Z</news:publication_date>
      <news:title>FiEE dispara sus ingresos un 382% hasta 9,6 M$ y vuelve a beneficios</news:title>
      <news:keywords>fiee-inc, nasdaq-fiee, saas-mcn-services, phygital-art-advisory, small-cap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/fiee营收飙升382-扭亏为盈</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:34:04.213Z</news:publication_date>
      <news:title>FiEE营收飙升382%至960万美元，净利润扭亏为盈</news:title>
      <news:keywords>fiee-inc, nasdaq-fiee, saas-mcn-services, phygital-art-advisory, small-cap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/fiee-chiffre-affaires-bondit-382-resultat-net-positif</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:34:04.213Z</news:publication_date>
      <news:title>FiEE : le chiffre d&apos;affaires bondit de 382 % à 9,6 M$ et le résultat net devient positif</news:title>
      <news:keywords>fiee-inc, nasdaq-fiee, saas-mcn-services, phygital-art-advisory, small-cap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/fiie-ricavi-382-utile-netto-positivo-saas-consulenza</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:34:04.212Z</news:publication_date>
      <news:title>FiEE ricavi +382% a 9,6 mln $, utile positivo</news:title>
      <news:keywords>fiee-inc, nasdaq-fiee, saas-mcn-services, phygital-art-advisory, small-cap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/fiee-q3-2026-revenue-surge-382-percent-net-income-turnaround</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:34:04.212Z</news:publication_date>
      <news:title>FiEE Revenue Jumps 382% to $9.6M as Net Income Turns Positive</news:title>
      <news:keywords>fiee-inc, nasdaq-fiee, saas-mcn-services, phygital-art-advisory, small-cap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/gaxos-ai-chiffre-affaires-t3-bondit-464-9-pub-en-baisse</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:33:07.900Z</news:publication_date>
      <news:title>Gaxos.ai : le chiffre d&apos;affaires T3 bondit de 464,9 % à 2,81 M$</news:title>
      <news:keywords>gaxos-ai, gxai, quarterly-earnings, ai-stocks, small-cap-equities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/gaxos-ai-q3营收增464</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:33:07.900Z</news:publication_date>
      <news:title>Gaxos.ai第三季度营收飙升464.9%至281万美元，广告支出下降</news:title>
      <news:keywords>gaxos-ai, gxai, quarterly-earnings, ai-stocks, small-cap-equities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/gaxos-ai-ingresos-t3-464-9-por-ciento-gasto-publicitario-cae</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:33:07.900Z</news:publication_date>
      <news:title>Gaxos.ai dispara sus ingresos un 464,9% en el T3 hasta 2,81 M$ y recorta el gasto publicitario</news:title>
      <news:keywords>gaxos-ai, gxai, quarterly-earnings, ai-stocks, small-cap-equities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/gaxos-ai-ricavi-q3-crescita-464-9-spesa-pubblicitaria-cala</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:33:07.898Z</news:publication_date>
      <news:title>Gaxos.ai: ricavi Q3 +464,9% a 2,81 mln $, cala la spesa adv</news:title>
      <news:keywords>gaxos-ai, gxai, quarterly-earnings, ai-stocks, small-cap-equities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/gaxos-ai-q3-2026-revenue-jumps-464-9-percent-ad-spend-falls</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:33:07.898Z</news:publication_date>
      <news:title>Gaxos.ai Q3 Revenue Jumps 464.9% to $2.81M as Ad Spend Falls</news:title>
      <news:keywords>gaxos-ai, gxai, quarterly-earnings, ai-stocks, small-cap-equities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/景顺ivr股息降至0-12美元</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:32:11.350Z</news:publication_date>
      <news:title>景顺抵押资本将月度股息下调至0.12美元</news:title>
      <news:keywords>invesco-mortgage-capital, ivr-dividend, mortgage-reit, agency-rmbs, book-value</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/invesco-mortgage-capital-recorta-dividendo-mensual-012-dolares</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:32:11.350Z</news:publication_date>
      <news:title>Invesco Mortgage Capital recorta su dividendo mensual a 0,12 $</news:title>
      <news:keywords>invesco-mortgage-capital, ivr-dividend, mortgage-reit, agency-rmbs, book-value</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/invesco-mortgage-capital-reduit-dividende-mensuel-012-dollar</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:32:11.350Z</news:publication_date>
      <news:title>Invesco Mortgage Capital réduit son dividende mensuel à 0,12 $</news:title>
      <news:keywords>invesco-mortgage-capital, ivr-dividend, mortgage-reit, agency-rmbs, book-value</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/invesco-mortgage-capital-taglia-dividendo-mensile-012-dollari</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:32:11.350Z</news:publication_date>
      <news:title>Invesco Mortgage Capital taglia il dividendo mensile a 0,12 dollari</news:title>
      <news:keywords>invesco-mortgage-capital, ivr-dividend, mortgage-reit, agency-rmbs, book-value</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/invesco-mortgage-capital-ivr-november-2026-dividend-book-value-701</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:32:11.350Z</news:publication_date>
      <news:title>Invesco Mortgage Capital Cuts Monthly Dividend to $0.12</news:title>
      <news:keywords>invesco-mortgage-capital, ivr-dividend, mortgage-reit, agency-rmbs, book-value</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/astrotech-reduce-perdida-q1-2-9-millones-gastos-operativos-15-7</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:26:01.205Z</news:publication_date>
      <news:title>Astrotech reduce pérdida del Q1 a 2,9 M$ con gastos operativos -15,7%</news:title>
      <news:keywords>astrotech, astc, astc-stock, micro-cap-earnings, mass-spectrometry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/astrotech亏损收窄现金下降</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:26:01.205Z</news:publication_date>
      <news:title>Astrotech第一财季亏损收窄至290万美元 运营支出下降15.7%</news:title>
      <news:keywords>astrotech, astc, astc-stock, micro-cap-earnings, mass-spectrometry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/astrotech-perte-t1-reduite-charges-exploitation-baisse</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:26:01.204Z</news:publication_date>
      <news:title>Astrotech réduit sa perte au T1 à 2,9 M$</news:title>
      <news:keywords>astrotech, astc, astc-stock, micro-cap-earnings, mass-spectrometry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/astrotech-perdita-q1-2027-ridotta-cassa-rischio-diluizione</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:26:01.204Z</news:publication_date>
      <news:title>Perdita Q1 di Astrotech si riduce a 2,9 mln, OpEx -15,7%</news:title>
      <news:keywords>astrotech, astc, astc-stock, micro-cap-earnings, mass-spectrometry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/astrotech-astc-q1-fy2027-loss-narrows-2-9-million-opex</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:26:01.203Z</news:publication_date>
      <news:title>Astrotech Q1 Loss Narrows to $2.9M as OpEx Falls 15.7%</news:title>
      <news:keywords>astrotech, astc, astc-stock, micro-cap-earnings, mass-spectrometry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/英伟达无黄仁勋财报anthropic-900亿ipo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:19:51.831Z</news:publication_date>
      <news:title>英伟达无黄仁勋发布财报，Anthropic定价900亿IPO</news:title>
      <news:keywords>nvidia-earnings, anthropic-ipo, fed-rate-hike, us-consumer, october-cpi</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/nvidia-informa-sin-jensen-anthropic-fija-opv-90-mil-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:19:51.831Z</news:publication_date>
      <news:title>Nvidia informa sin Jensen mientras Anthropic fija su OPV de 90.000M$</news:title>
      <news:keywords>nvidia-earnings, anthropic-ipo, fed-rate-hike, us-consumer, october-cpi</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/nvidia-sans-jensen-anthropic-ipo-90-milliards</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:19:51.830Z</news:publication_date>
      <news:title>Nvidia publie sans Jensen, Anthropic valorise son IPO à 90 Md$</news:title>
      <news:keywords>nvidia-earnings, anthropic-ipo, fed-rate-hike, us-consumer, october-cpi</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/nvidia-senza-jensen-anthropic-ipo-90-miliardi-settimana-ia</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:19:51.830Z</news:publication_date>
      <news:title>Nvidia senza Jensen, Anthropic quota IPO da 90 miliardi</news:title>
      <news:keywords>nvidia-earnings, anthropic-ipo, fed-rate-hike, us-consumer, october-cpi</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/nvidia-earnings-jensen-departure-anthropic-ipo-90-billion</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:19:51.829Z</news:publication_date>
      <news:title>Nvidia Reports Without Jensen as Anthropic Prices $90B IPO</news:title>
      <news:keywords>nvidia-earnings, anthropic-ipo, fed-rate-hike, us-consumer, october-cpi</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/annovis-bio-perdidas-t3-022-lectura-duet-ad-marzo-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:18:51.260Z</news:publication_date>
      <news:title>Annovis Bio reduce pérdidas del T3 a 0,22 $ y fija lectura DUET-AD en marzo de 2027</news:title>
      <news:keywords>annovis-bio, anvs, buntanetap, alzheimers-disease, biotech-clinical-trials</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/annovis-bio-anvs-亏损收窄-duet-ad</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:18:51.260Z</news:publication_date>
      <news:title>Annovis Bio第三季度亏损收窄至每股0.22美元，DUET-AD数据读出定于2027年3月</news:title>
      <news:keywords>annovis-bio, anvs, buntanetap, alzheimers-disease, biotech-clinical-trials</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/annovis-bio-perte-t3-reduite-lecture-duet-ad-mars-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:18:51.260Z</news:publication_date>
      <news:title>Annovis Bio : perte T3 réduite à 0,22 $, lecture DUET-AD en mars 2027</news:title>
      <news:keywords>annovis-bio, anvs, buntanetap, alzheimers-disease, biotech-clinical-trials</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/annovis-bio-perdita-q3-022-lettura-duet-ad-marzo-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:18:51.260Z</news:publication_date>
      <news:title>Annovis Bio: perdita Q3 a 0,22 $, lettura DUET-AD a marzo 2027</news:title>
      <news:keywords>annovis-bio, anvs, buntanetap, alzheimers-disease, biotech-clinical-trials</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/annovis-bio-q3-2026-loss-narrows-duet-ad-readout-march-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:18:51.260Z</news:publication_date>
      <news:title>Annovis Bio Q3 Loss Narrows to $0.22 as DUET-AD Readout Set for March 2027</news:title>
      <news:keywords>annovis-bio, anvs, buntanetap, alzheimers-disease, biotech-clinical-trials</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/pharmacyte-pmcb反向拆股</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:12:38.794Z</news:publication_date>
      <news:title>PharmaCyte Biotech设定1拆19反向拆股，PMCB于11月13日调整后交易</news:title>
      <news:keywords>pharmacyte-biotech, reverse-stock-split, pmcb-stock, nasdaq-minimum-bid-price, microcap-equities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/pharmacyte-biotech-contrasplit-1x19-pmcb-cotiza-ajustado-13-nov</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:12:38.794Z</news:publication_date>
      <news:title>PharmaCyte Biotech fija un contrasplit 1x19, PMCB cotiza ajustado el 13 nov</news:title>
      <news:keywords>pharmacyte-biotech, reverse-stock-split, pmcb-stock, nasdaq-minimum-bid-price, microcap-equities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/pharmacyte-biotech-1-for-19-reverse-stock-split-pmcb-nasdaq</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:12:38.793Z</news:publication_date>
      <news:title>PharmaCyte Biotech Sets 1-for-19 Reverse Split, PMCB Trades Adjusted Nov 13</news:title>
      <news:keywords>pharmacyte-biotech, reverse-stock-split, pmcb-stock, nasdaq-minimum-bid-price, microcap-equities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/pharmacyte-biotech-regroupement-1-pour-19-pmcb-ajuste-13-novembre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:12:38.793Z</news:publication_date>
      <news:title>PharmaCyte Biotech fixe un regroupement 1 pour 19, PMCB ajusté le 13 nov.</news:title>
      <news:keywords>pharmacyte-biotech, reverse-stock-split, pmcb-stock, nasdaq-minimum-bid-price, microcap-equities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/pharmacyte-biotech-frazionamento-inverso-1-a-19-pmcb-nasdaq</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:12:38.793Z</news:publication_date>
      <news:title>PharmaCyte Biotech fissa frazionamento inverso 1-a-19, PMCB scambia rettificato il 13 novembre</news:title>
      <news:keywords>pharmacyte-biotech, reverse-stock-split, pmcb-stock, nasdaq-minimum-bid-price, microcap-equities</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/boston-omaha-reduit-perte-t3-rachat-85-millions</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:11:30.695Z</news:publication_date>
      <news:title>Boston Omaha réduit sa perte au T3 à 192 K$ et porte son rachat à 85 M$</news:title>
      <news:keywords>boston-omaha, BOC, share-repurchase, billboard-advertising, broadband-telecom</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/波士顿奥马哈回购8500万</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:11:30.695Z</news:publication_date>
      <news:title>波士顿奥马哈第三季度亏损收窄至19.2万美元，回购授权提升至8500万美元</news:title>
      <news:keywords>boston-omaha, BOC, share-repurchase, billboard-advertising, broadband-telecom</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/boston-omaha-reduce-perdida-trimestral-y-eleva-recompra-acciones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:11:30.695Z</news:publication_date>
      <news:title>Boston Omaha reduce su pérdida del tercer trimestre a 192.000 $ y eleva la recompra a 85 millones $</news:title>
      <news:keywords>boston-omaha, BOC, share-repurchase, billboard-advertising, broadband-telecom</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/boston-omaha-riduce-perdita-q3-buyback-85-milioni</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:11:30.694Z</news:publication_date>
      <news:title>Boston Omaha riduce la perdita del Q3 a 192K dollari, buyback a 85 milioni</news:title>
      <news:keywords>boston-omaha, BOC, share-repurchase, billboard-advertising, broadband-telecom</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/boston-omaha-q3-2026-loss-narrows-share-repurchase-85-million</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:11:30.693Z</news:publication_date>
      <news:title>Boston Omaha Narrows Q3 Loss to $192K, Lifts Buyback to $85M</news:title>
      <news:keywords>boston-omaha, BOC, share-repurchase, billboard-advertising, broadband-telecom</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/irulya第三季度亏损现金至2028</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:10:31.853Z</news:publication_date>
      <news:title>IRulya Therapeutics公布第三季度亏损2770万美元，现金可支撑至2028年</news:title>
      <news:keywords>irulya-therapeutics, irma-stock, lam-001, biotech-earnings, clinical-stage-biopharma</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/irulya-therapeutics-perdidas-t3-2026-caja-105-millones-hasta-2028</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:10:31.853Z</news:publication_date>
      <news:title>IRulya Therapeutics registra pérdidas de 27,7 M$ en el T3 y caja hasta 2028</news:title>
      <news:keywords>irulya-therapeutics, irma-stock, lam-001, biotech-earnings, clinical-stage-biopharma</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/irulya-therapeutics-perte-t3-tresorerie-2028</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:10:31.853Z</news:publication_date>
      <news:title>IRulya Therapeutics publie une perte de 27,7 M$ au T3 et une trésorerie jusqu&apos;en 2028</news:title>
      <news:keywords>irulya-therapeutics, irma-stock, lam-001, biotech-earnings, clinical-stage-biopharma</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/irulya-therapeutics-perdita-q3-2026-cassa-fino-2028-lam-001</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:10:31.853Z</news:publication_date>
      <news:title>IRulya Therapeutics registra perdita di 27,7 mln nel Q3, cassa fino al 2028</news:title>
      <news:keywords>irulya-therapeutics, irma-stock, lam-001, biotech-earnings, clinical-stage-biopharma</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/irulya-therapeutics-q3-2026-net-loss-cash-runway-irma-lam-001</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:10:31.853Z</news:publication_date>
      <news:title>IRulya Therapeutics Posts $27.7M Q3 Loss, $105M Runway to 2028</news:title>
      <news:keywords>irulya-therapeutics, irma-stock, lam-001, biotech-earnings, clinical-stage-biopharma</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/indaptus-therapeutics-perte-t3-reduite-coupe-rd-pivot-sommeil</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:09:27.720Z</news:publication_date>
      <news:title>Indaptus Therapeutics : perte T3 réduite à 1,0 M$ après coupe de 82 % en R&amp;D</news:title>
      <news:keywords>indaptus-therapeutics, indp, biotech-earnings, immunotherapy, private-placement</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/indaptus研发削减82</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:09:27.720Z</news:publication_date>
      <news:title>Indaptus Therapeutics第三季度亏损收窄至100万美元，研发削减82%</news:title>
      <news:keywords>indaptus-therapeutics, indp, biotech-earnings, immunotherapy, private-placement</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/indaptus-therapeutics-reduce-perdida-t3-recorte-id-pivot-sueno</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:09:27.720Z</news:publication_date>
      <news:title>Indaptus Therapeutics reduce su pérdida del T3 a 1,0 M$ tras recortar I+D un 82%</news:title>
      <news:keywords>indaptus-therapeutics, indp, biotech-earnings, immunotherapy, private-placement</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/indaptus-therapeutics-perdita-q3-2026-rs-tagliata-82percento</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:09:27.720Z</news:publication_date>
      <news:title>Indaptus Therapeutics: perdita Q3 a 1,0 mln, R&amp;S -82%</news:title>
      <news:keywords>indaptus-therapeutics, indp, biotech-earnings, immunotherapy, private-placement</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/indaptus-therapeutics-q3-2026-loss-narrows-rd-cut-24m-placement</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:09:27.719Z</news:publication_date>
      <news:title>Indaptus Therapeutics Q3 Loss Narrows to $1.0M on 82% R&amp;D Cut</news:title>
      <news:keywords>indaptus-therapeutics, indp, biotech-earnings, immunotherapy, private-placement</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/wise跨境交易量1410亿</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:03:21.381Z</news:publication_date>
      <news:title>Wise大涨8.55%，跨境交易量达1410亿美元</news:title>
      <news:keywords>wise-group, wse-stock, cross-border-payments, fintech-earnings, nasdaq-dual-listing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/wise-sube-855-volumen-transfronterizo-141000-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:03:21.381Z</news:publication_date>
      <news:title>Wise sube 8,55% al alcanzar 141.000 M$ en volumen transfronterizo</news:title>
      <news:keywords>wise-group, wse-stock, cross-border-payments, fintech-earnings, nasdaq-dual-listing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/wise-utili-semestre-fiscale-2027-volumi-transfrontalieri-141-miliardi</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:03:21.380Z</news:publication_date>
      <news:title>Wise balza dell&apos;8,55% con volumi transfrontalieri a 141 miliardi di dollari</news:title>
      <news:keywords>wise-group, wse-stock, cross-border-payments, fintech-earnings, nasdaq-dual-listing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/wise-bondit-855-volume-transfrontalier-141-milliards</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:03:21.380Z</news:publication_date>
      <news:title>Wise bondit de 8,55 %, le volume transfrontalier atteint 141 Md$</news:title>
      <news:keywords>wise-group, wse-stock, cross-border-payments, fintech-earnings, nasdaq-dual-listing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/wise-wse-stock-surge-cross-border-payments-141-billion-h1-fy2027</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T13:03:21.380Z</news:publication_date>
      <news:title>Wise Surges 8.55% as Cross-Border Volume Hits $141 Billion</news:title>
      <news:keywords>wise-group, wse-stock, cross-border-payments, fintech-earnings, nasdaq-dual-listing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/liftoff-mobile-lfto飙升31</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:57:15.070Z</news:publication_date>
      <news:title>Liftoff Mobile股价因Q3超预期并上调指引飙升31%</news:title>
      <news:keywords>liftoff-mobile, lfto-stock, mobile-advertising, cortex-ai, q3-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/liftoff-mobile-sube-31-tras-superar-q3-y-elevar-previsiones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:57:15.070Z</news:publication_date>
      <news:title>Liftoff Mobile sube 31% tras superar el Q3 y elevar previsiones</news:title>
      <news:keywords>liftoff-mobile, lfto-stock, mobile-advertising, cortex-ai, q3-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/liftoff-mobile-lfto-stock-surges-q3-earnings-raised-2026-outlook</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:57:15.069Z</news:publication_date>
      <news:title>Liftoff Mobile Stock Skyrockets 31% on Q3 Beat, Raised Outlook</news:title>
      <news:keywords>liftoff-mobile, lfto-stock, mobile-advertising, cortex-ai, q3-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/liftoff-mobile-bondit-31-resultats-q3-previsions-relevees</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:57:15.069Z</news:publication_date>
      <news:title>Liftoff Mobile bondit de 31% après des résultats Q3 et des prévisions relevées</news:title>
      <news:keywords>liftoff-mobile, lfto-stock, mobile-advertising, cortex-ai, q3-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/liftoff-mobile-azioni-31-q3-outlook-alzato</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:57:15.069Z</news:publication_date>
      <news:title>Liftoff Mobile vola del 31% su Q3 e outlook alzato</news:title>
      <news:keywords>liftoff-mobile, lfto-stock, mobile-advertising, cortex-ai, q3-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/英伟达中国营收20-质疑</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:56:21.007Z</news:publication_date>
      <news:title>英伟达临时CEO接手中国风险，20%营收遭质疑</news:title>
      <news:keywords>nvidia, nvda, export-controls, culper-research, china-ai-chips, semiconductors</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/nvidia-ceo-interino-riesgo-china-ingresos-cuestionados</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:56:21.006Z</news:publication_date>
      <news:title>El CEO interino de Nvidia hereda el riesgo China mientras se cuestiona el 20% de los ingresos</news:title>
      <news:keywords>nvidia, nvda, export-controls, culper-research, china-ai-chips, semiconductors</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/nvidia-pdg-interim-risque-chine-20-pourcent-chiffre-affaires</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:56:21.006Z</news:publication_date>
      <news:title>Le PDG par intérim de Nvidia hérite du risque chinois, 20 % du chiffre d&apos;affaires en question</news:title>
      <news:keywords>nvidia, nvda, export-controls, culper-research, china-ai-chips, semiconductors</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/nvidia-ad-interim-rischio-cina-ricavi-sotto-esame</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:56:21.005Z</news:publication_date>
      <news:title>L&apos;AD interim di Nvidia eredita il rischio Cina: il 20% dei ricavi sotto esame</news:title>
      <news:keywords>nvidia, nvda, export-controls, culper-research, china-ai-chips, semiconductors</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/nvidia-interim-ceo-china-revenue-risk-culper-research</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:56:21.004Z</news:publication_date>
      <news:title>Nvidia Interim CEO Inherits China Risk as 20% Revenue Questioned</news:title>
      <news:keywords>nvidia, nvda, export-controls, culper-research, china-ai-chips, semiconductors</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/nebius暴跌25-数据中心延期</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:50:20.818Z</news:publication_date>
      <news:title>Nebius暴跌25%，分析师称数据中心延期为&quot;小瑕疵&quot;</news:title>
      <news:keywords>nebius-stock, nbis, neocloud-stocks, rosenblatt-securities, data-center-delay</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/nebius-cae-25-analista-retraso-centro-datos-leve-mancha</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:50:20.817Z</news:publication_date>
      <news:title>Nebius cae un 25%: analista ve el retraso del centro de datos una &apos;leve mancha&apos;</news:title>
      <news:keywords>nebius-stock, nbis, neocloud-stocks, rosenblatt-securities, data-center-delay</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/nebius-crolla-25-ritardo-data-center-lieve-macchia</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:50:20.816Z</news:publication_date>
      <news:title>Nebius crolla del 25%, analista: ritardo data center è &apos;lieve macchia&apos;</news:title>
      <news:keywords>nebius-stock, nbis, neocloud-stocks, rosenblatt-securities, data-center-delay</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/nebius-chute-25-analyste-retard-centre-donnees-legere-ombre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:50:20.816Z</news:publication_date>
      <news:title>Nebius chute de 25 %, un analyste qualifie le retard du centre de données de « légère ombre »</news:title>
      <news:keywords>nebius-stock, nbis, neocloud-stocks, rosenblatt-securities, data-center-delay</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/nebius-stock-falls-25-percent-analyst-buy-rating-data-center-delay</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:50:20.816Z</news:publication_date>
      <news:title>Nebius Falls 25% as Analyst Calls Data Center Delay a &apos;Slight Blemish&apos;</news:title>
      <news:keywords>nebius-stock, nbis, neocloud-stocks, rosenblatt-securities, data-center-delay</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/vuzix-q3-2026-ingresos-caen-38-perdida-neta-aumenta</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:49:18.957Z</news:publication_date>
      <news:title>Vuzix Q3 2026: ingresos caen 38% a 0,7 M$ y pérdida neta aumenta</news:title>
      <news:keywords>vuzix, vuzix-q3-2026-earnings, ar-smart-glasses, co-packaged-optics, waveguide-manufacturing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/vuzix三季度营收降38</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:49:18.957Z</news:publication_date>
      <news:title>Vuzix 2026年第三季度：营收下降38%至70万美元，净亏损扩大</news:title>
      <news:keywords>vuzix, vuzix-q3-2026-earnings, ar-smart-glasses, co-packaged-optics, waveguide-manufacturing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/vuzix-t3-2026-chiffre-affaires-en-baisse-perte-nette-elargie</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:49:18.957Z</news:publication_date>
      <news:title>Vuzix T3 2026 : chiffre d&apos;affaires -38% à 0,7 M$, perte nette élargie</news:title>
      <news:keywords>vuzix, vuzix-q3-2026-earnings, ar-smart-glasses, co-packaged-optics, waveguide-manufacturing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/vuzix-q3-2026-ricavi-in-calo-perdita-netta-in-aumento</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:49:18.955Z</news:publication_date>
      <news:title>Vuzix Q3 2026: ricavi -38% a 0,7 mln, perdita netta sale</news:title>
      <news:keywords>vuzix, vuzix-q3-2026-earnings, ar-smart-glasses, co-packaged-optics, waveguide-manufacturing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/vuzix-q3-2026-revenue-falls-38-net-loss-widens-causeway</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:49:18.955Z</news:publication_date>
      <news:title>Vuzix Q3 2026: Revenue Falls 38% to $0.7M, Net Loss Widens</news:title>
      <news:keywords>vuzix, vuzix-q3-2026-earnings, ar-smart-glasses, co-packaged-optics, waveguide-manufacturing</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/zai-lab-zl-1503-bloquea-il-13-90-por-ciento-semana-12</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:43:13.368Z</news:publication_date>
      <news:title>ZL-1503 de Zai Lab bloquea IL-13 un 90% hasta la semana 12</news:title>
      <news:keywords>zai-lab, zl-1503, atopic-dermatitis, bispecific-antibody, il-13-inhibitor</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/再鼎医药zl-1503特应性皮炎</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:43:13.368Z</news:publication_date>
      <news:title>再鼎医药ZL-1503第12周IL-13抑制率达90%</news:title>
      <news:keywords>zai-lab, zl-1503, atopic-dermatitis, bispecific-antibody, il-13-inhibitor</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/zai-lab-zl-1503-inhibition-stat6-90-pourcent-semaine-12</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:43:13.367Z</news:publication_date>
      <news:title>ZL-1503 de Zai Lab bloque l&apos;IL-13 à 90% jusqu&apos;à la semaine 12</news:title>
      <news:keywords>zai-lab, zl-1503, atopic-dermatitis, bispecific-antibody, il-13-inhibitor</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/zai-lab-zl-1503-blocca-il-13-90-per-cento-settimana-12</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:43:13.367Z</news:publication_date>
      <news:title>ZL-1503 di Zai Lab blocca IL-13 al 90% fino alla settimana 12</news:title>
      <news:keywords>zai-lab, zl-1503, atopic-dermatitis, bispecific-antibody, il-13-inhibitor</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/zai-lab-zl-1503-atopic-dermatitis-phase-1-biomarker-results</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:43:13.366Z</news:publication_date>
      <news:title>Zai Lab&apos;s ZL-1503 Blocks IL-13 by 90% Through Week 12</news:title>
      <news:keywords>zai-lab, zl-1503, atopic-dermatitis, bispecific-antibody, il-13-inhibitor</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/pedevco三季度营收飙升411</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:42:12.293Z</news:publication_date>
      <news:title>PEDEVCO第三季度营收飙升411%至3550万美元，净亏损达920万美元</news:title>
      <news:keywords>pedevco, ped-stock, oil-gas-earnings, rockies-shale, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/pedevco-q3-ingresos-suben-411-perdida-neta-9-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:42:12.293Z</news:publication_date>
      <news:title>PEDEVCO Q3 ingresos suben 411% a 35,5M$, pérdida neta 9,2M$</news:title>
      <news:keywords>pedevco, ped-stock, oil-gas-earnings, rockies-shale, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/pedevco-ricavi-q3-2026-crescita-411-percento-perdita-netta</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:42:12.292Z</news:publication_date>
      <news:title>PEDEVCO: ricavi Q3 +411% a 35,5 mln, perdita netta 9,2 mln</news:title>
      <news:keywords>pedevco, ped-stock, oil-gas-earnings, rockies-shale, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/pedevco-t3-chiffre-affaires-411-pourcent-perte-nette-9-2-millions</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:42:12.292Z</news:publication_date>
      <news:title>PEDEVCO T3 : chiffre d&apos;affaires +411% à 35,5 M$, perte nette de 9,2 M$</news:title>
      <news:keywords>pedevco, ped-stock, oil-gas-earnings, rockies-shale, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/pedevco-q3-2026-revenue-411-percent-net-loss-derivatives</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:42:12.291Z</news:publication_date>
      <news:title>PEDEVCO Q3 Revenue Jumps 411% to $35.5M, Net Loss Hits $9.2M</news:title>
      <news:keywords>pedevco, ped-stock, oil-gas-earnings, rockies-shale, q3-2026-results</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/americas-gold-and-silver-incumple-ingresos-q3-usas-cae-15</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:36:03.007Z</news:publication_date>
      <news:title>Americas Gold and Silver incumple ingresos del Q3 y USAS cae 15%</news:title>
      <news:keywords>americas-gold-and-silver, usas-stock, silver-mining, q3-2026-earnings, cosala-silver-production</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/美洲金银usas营收不及预期</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:36:03.007Z</news:publication_date>
      <news:title>美洲金银Q3营收不及预期，USAS股价下跌15%</news:title>
      <news:keywords>americas-gold-and-silver, usas-stock, silver-mining, q3-2026-earnings, cosala-silver-production</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/americas-gold-and-silver-rate-t3-usas-chute-de-15-pourcent</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:36:03.007Z</news:publication_date>
      <news:title>Americas Gold and Silver rate le T3, USAS chute de 15 %</news:title>
      <news:keywords>americas-gold-and-silver, usas-stock, silver-mining, q3-2026-earnings, cosala-silver-production</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/americas-gold-silver-ricavi-q3-usas-calo-15-percento</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:36:03.006Z</news:publication_date>
      <news:title>Americas Gold and Silver delude i ricavi Q3, USAS -15%</news:title>
      <news:keywords>americas-gold-and-silver, usas-stock, silver-mining, q3-2026-earnings, cosala-silver-production</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/americas-gold-silver-usas-q3-2026-revenue-miss-record-silver-output</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:36:03.005Z</news:publication_date>
      <news:title>Americas Gold and Silver Misses Q3 Revenue as USAS Falls 15%</news:title>
      <news:keywords>americas-gold-and-silver, usas-stock, silver-mining, q3-2026-earnings, cosala-silver-production</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/美国储蓄率3-8-消费者裂痕</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:29:58.166Z</news:publication_date>
      <news:title>美国消费者现裂痕：储蓄率降至3.8%</news:title>
      <news:keywords>us-consumer, retail-sales, savings-rate, walmart-earnings, target-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/consumidor-eeuu-grietas-tasa-ahorro-38-ventas-minoristas</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:29:58.166Z</news:publication_date>
      <news:title>El consumidor de EE. UU. muestra grietas: tasa de ahorro cae al 3,8%</news:title>
      <news:keywords>us-consumer, retail-sales, savings-rate, walmart-earnings, target-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/consommateur-americain-fissures-taux-epargne-3-8</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:29:58.166Z</news:publication_date>
      <news:title>Le consommateur américain montre des fissures, taux d&apos;épargne à 3,8%</news:title>
      <news:keywords>us-consumer, retail-sales, savings-rate, walmart-earnings, target-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/consumatore-usa-crepe-tasso-risparmio-minimo-2022</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:29:58.165Z</news:publication_date>
      <news:title>Il consumatore USA mostra crepe: tasso di risparmio al 3,8%</news:title>
      <news:keywords>us-consumer, retail-sales, savings-rate, walmart-earnings, target-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/us-consumer-cracks-savings-rate-retail-sales-walmart-target-earnings</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:29:58.165Z</news:publication_date>
      <news:title>US Consumer Shows Cracks as Savings Rate Hits 3.8%</news:title>
      <news:keywords>us-consumer, retail-sales, savings-rate, walmart-earnings, target-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/figure目标价下调至50美元</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:28:57.524Z</news:publication_date>
      <news:title>Figure分析师下调目标价至50美元，维持买入评级，成交量激增135%</news:title>
      <news:keywords>figure-technology, figr-stock, needham-price-target, blockchain-lending, kiavi-acquisition</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/analista-recorta-precio-objetivo-figure-mantiene-compra-volumen</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:28:57.524Z</news:publication_date>
      <news:title>Analista recorta precio objetivo de Figure a 50 $ y mantiene compra con volumen +135%</news:title>
      <news:keywords>figure-technology, figr-stock, needham-price-target, blockchain-lending, kiavi-acquisition</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/figure-needham-objectif-50-maintenir-achat-volume-135</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:28:57.524Z</news:publication_date>
      <news:title>Figure : Needham réduit son objectif à 50 $, maintient l&apos;achat sur un volume en hausse de 135 %</news:title>
      <news:keywords>figure-technology, figr-stock, needham-price-target, blockchain-lending, kiavi-acquisition</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/figure-technology-needham-price-target-buyback-q3-volume-surge</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:28:57.523Z</news:publication_date>
      <news:title>Figure Analyst Cuts PT to $50, Keeps Buy on 135% Volume Surge</news:title>
      <news:keywords>figure-technology, figr-stock, needham-price-target, blockchain-lending, kiavi-acquisition</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/analista-taglia-target-figure-50-dollari-conferma-buy-volumi</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:28:57.523Z</news:publication_date>
      <news:title>Analista taglia target di Figure a 50$, conferma Buy su volumi +135%</news:title>
      <news:keywords>figure-technology, figr-stock, needham-price-target, blockchain-lending, kiavi-acquisition</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/newton-golf-ventas-q3-caen-47-aviso-nasdaq-fondos-propios</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:27:59.397Z</news:publication_date>
      <news:title>Newton Golf: ventas del tercer trimestre caen un 47% hasta 1,4 M$ y aviso de Nasdaq sobre fondos propios</news:title>
      <news:keywords>newton-golf, nwtg, nasdaq-listing-compliance, going-concern, golf-equipment-stocks</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/牛顿高尔夫nwtg纳斯达克股权</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:27:59.397Z</news:publication_date>
      <news:title>牛顿高尔夫第三季度销售额下降47%至140万美元，收到纳斯达克股权通知</news:title>
      <news:keywords>newton-golf, nwtg, nasdaq-listing-compliance, going-concern, golf-equipment-stocks</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/newton-golf-ventes-t3-en-baisse-avis-nasdaq-fonds-propres</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:27:59.396Z</news:publication_date>
      <news:title>Newton Golf : ventes T3 -47% à 1,4 M$, avis Nasdaq</news:title>
      <news:keywords>newton-golf, nwtg, nasdaq-listing-compliance, going-concern, golf-equipment-stocks</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/newton-golf-q3-2026-sales-fall-nasdaq-equity-notice</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:27:59.395Z</news:publication_date>
      <news:title>Newton Golf Q3 Sales Fall 47% to $1.4M, Nasdaq Equity Notice</news:title>
      <news:keywords>newton-golf, nwtg, nasdaq-listing-compliance, going-concern, golf-equipment-stocks</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/newton-golf-vendite-q3-calo-47-nasdaq-patrimonio-netto</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:27:59.395Z</news:publication_date>
      <news:title>Newton Golf: vendite Q3 -47% a 1,4 mln, avviso Nasdaq</news:title>
      <news:keywords>newton-golf, nwtg, nasdaq-listing-compliance, going-concern, golf-equipment-stocks</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/whitehorse赎回whfcl票据</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:26:57.068Z</news:publication_date>
      <news:title>WhiteHorse Finance赎回WHFCL票据，3450万美元12月15日到期</news:title>
      <news:keywords>whitehorse-finance, whfcl-notes, business-development-company, note-redemption, nasdaq-delisting</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/whitehorse-finance-amortiza-pagares-whfcl-34-millones-diciembre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:26:57.068Z</news:publication_date>
      <news:title>WhiteHorse Finance amortiza los pagarés WHFCL, 34,5 M$ el 15 dic</news:title>
      <news:keywords>whitehorse-finance, whfcl-notes, business-development-company, note-redemption, nasdaq-delisting</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/whitehorse-finance-rembourse-billets-whfcl-34-5-millions</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:26:57.068Z</news:publication_date>
      <news:title>WhiteHorse Finance rembourse les billets WHFCL, 34,5 M$ le 15 déc.</news:title>
      <news:keywords>whitehorse-finance, whfcl-notes, business-development-company, note-redemption, nasdaq-delisting</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/whitehorse-finance-redeems-7-875-notes-due-2028-whfcl-delisting</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:26:57.067Z</news:publication_date>
      <news:title>WhiteHorse Finance Redeems WHFCL Notes, $34.5M Due Dec 15</news:title>
      <news:keywords>whitehorse-finance, whfcl-notes, business-development-company, note-redemption, nasdaq-delisting</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/whitehorse-finance-rimborsa-note-whfcl-34-milioni-15-dicembre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:26:57.067Z</news:publication_date>
      <news:title>WhiteHorse Finance rimborsa le note WHFCL, 34,5 milioni il 15 dicembre</news:title>
      <news:keywords>whitehorse-finance, whfcl-notes, business-development-company, note-redemption, nasdaq-delisting</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/iren-cae-12-8-bitcoin-bajo-70000-nvda-desplome-mineras-ia</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:20:50.209Z</news:publication_date>
      <news:title>IREN cae un 12,8% al bajar Bitcoin de 70.000 $</news:title>
      <news:keywords>iren-stock, bitcoin-below-70000, crypto-equities-selloff, nvidia-leadership-change, data-center-restrictions</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/比特币跌破7万iren暴跌</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:20:50.209Z</news:publication_date>
      <news:title>比特币跌破7万美元，IREN股价暴跌12.8%</news:title>
      <news:keywords>iren-stock, bitcoin-below-70000, crypto-equities-selloff, nvidia-leadership-change, data-center-restrictions</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/iren-chute-12-8-bitcoin-sous-70-000-nvda-baisse</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:20:50.209Z</news:publication_date>
      <news:title>IREN chute de 12,8 % alors que le Bitcoin passe sous 70 000 $</news:title>
      <news:keywords>iren-stock, bitcoin-below-70000, crypto-equities-selloff, nvidia-leadership-change, data-center-restrictions</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/iren-crolla-bitcoin-sotto-70mila-nvidia-ai-data-center</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:20:50.208Z</news:publication_date>
      <news:title>IREN crolla del 12,8% con Bitcoin sotto i 70.000 dollari</news:title>
      <news:keywords>iren-stock, bitcoin-below-70000, crypto-equities-selloff, nvidia-leadership-change, data-center-restrictions</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/iren-stock-slumps-bitcoin-falls-below-70000-crypto-selloff</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:20:50.208Z</news:publication_date>
      <news:title>IREN Stock Slumps 12.8% as Bitcoin Falls Below $70,000</news:title>
      <news:keywords>iren-stock, bitcoin-below-70000, crypto-equities-selloff, nvidia-leadership-change, data-center-restrictions</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/cormedix收购heron-childrens-place破产</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:19:50.622Z</news:publication_date>
      <news:title>CorMedix以1.45亿美元收购Heron资产，Children&apos;s Place申请第11章破产</news:title>
      <news:keywords>cormedix-heron-acquisition, childrens-place-chapter-11, morgan-stanley-vinyl-equity, fox-roku-acquisition, deal-dispatch</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/cormedix-compra-heron-childrens-place-capitulo-11</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:19:50.622Z</news:publication_date>
      <news:title>CorMedix compra activos de Heron por 145M$ mientras Children&apos;s Place se acoge al Capítulo 11</news:title>
      <news:keywords>cormedix-heron-acquisition, childrens-place-chapter-11, morgan-stanley-vinyl-equity, fox-roku-acquisition, deal-dispatch</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/cormedix-compra-asset-heron-childrens-place-chapter-11</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:19:50.621Z</news:publication_date>
      <news:title>CorMedix compra asset Heron per 145M$ mentre Children&apos;s Place fallisce</news:title>
      <news:keywords>cormedix-heron-acquisition, childrens-place-chapter-11, morgan-stanley-vinyl-equity, fox-roku-acquisition, deal-dispatch</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/cormedix-rachete-heron-childrens-place-chapter-11</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:19:50.621Z</news:publication_date>
      <news:title>CorMedix rachète les actifs de Heron pour 145 M$ et Children&apos;s Place se place sous Chapter 11</news:title>
      <news:keywords>cormedix-heron-acquisition, childrens-place-chapter-11, morgan-stanley-vinyl-equity, fox-roku-acquisition, deal-dispatch</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/cormedix-heron-assets-145m-childrens-place-chapter-11-deal-dispatch</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:19:50.620Z</news:publication_date>
      <news:title>CorMedix Buys Heron Assets for $145M as Children&apos;s Place Files Chapter 11</news:title>
      <news:keywords>cormedix-heron-acquisition, childrens-place-chapter-11, morgan-stanley-vinyl-equity, fox-roku-acquisition, deal-dispatch</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/amd-crolla-rally-chip-nasdaq-100-inflazione-produttori</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:18:51.893Z</news:publication_date>
      <news:title>AMD crolla del 10,5%, si sgonfia il rally dei chip: Nasdaq 100 -1,7%</news:title>
      <news:keywords>amd-stock, nvidia-huang-exit, nasdaq-100, semiconductor-selloff, dell-h800-servers</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/amd重挫芯片轮动逆转</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:18:51.893Z</news:publication_date>
      <news:title>AMD重挫10.5%芯片轮动逆转，纳斯达克100跌1.7%</news:title>
      <news:keywords>amd-stock, nvidia-huang-exit, nasdaq-100, semiconductor-selloff, dell-h800-servers</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/amd-cae-10-5-rally-chips-nasdaq-100-baja-1-7-nvidia-dell</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:18:51.893Z</news:publication_date>
      <news:title>AMD cae 10,5% al deshacerse el rally de chips y el Nasdaq 100 baja 1,7%</news:title>
      <news:keywords>amd-stock, nvidia-huang-exit, nasdaq-100, semiconductor-selloff, dell-h800-servers</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/amd-chute-10-5-rallye-puces-nasdaq-100-perd-1-7</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:18:51.893Z</news:publication_date>
      <news:title>AMD chute de 10,5 %, le rallye des puces se dénoue, le Nasdaq 100 perd 1,7 %</news:title>
      <news:keywords>amd-stock, nvidia-huang-exit, nasdaq-100, semiconductor-selloff, dell-h800-servers</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/amd-sinks-chip-rally-unwinds-nasdaq-100-falls-nvidia-huang</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:18:51.891Z</news:publication_date>
      <news:title>AMD Sinks 10.5% as Chip Rally Unwinds, Nasdaq 100 Falls 1.7%</news:title>
      <news:keywords>amd-stock, nvidia-huang-exit, nasdaq-100, semiconductor-selloff, dell-h800-servers</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/英伟达黄仁勋离职amd博通接棒</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:12:33.426Z</news:publication_date>
      <news:title>英伟达因黄仁勋离职暴跌13%，AMD与博通接棒称王</news:title>
      <news:keywords>nvidia, jensen-huang, amd, broadcom, semiconductor-stocks</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/nvidia-cae-13-huang-dimite-amd-broadcom-corona-sp100</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:12:33.426Z</news:publication_date>
      <news:title>Nvidia cae 13% al salir Huang, AMD y Broadcom toman la corona</news:title>
      <news:keywords>nvidia, jensen-huang, amd, broadcom, semiconductor-stocks</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/nvidia-crolla-huang-dimissioni-amd-broadcom-corona</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:12:33.425Z</news:publication_date>
      <news:title>Nvidia crolla del 13%, Huang si dimette: AMD e Broadcom sul trono</news:title>
      <news:keywords>nvidia, jensen-huang, amd, broadcom, semiconductor-stocks</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/nvidia-chute-13-pourcent-huang-part-amd-broadcom-couronne</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:12:33.425Z</news:publication_date>
      <news:title>Nvidia chute de 13 %, Huang part, AMD et Broadcom prennent la couronne</news:title>
      <news:keywords>nvidia, jensen-huang, amd, broadcom, semiconductor-stocks</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/nvidia-jensen-huang-resigns-ceo-amd-broadcom-rally-chip-rotation</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:12:33.425Z</news:publication_date>
      <news:title>Nvidia Sinks 13% as Huang Exits, AMD and Broadcom Take the Crown</news:title>
      <news:keywords>nvidia, jensen-huang, amd, broadcom, semiconductor-stocks</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/columbia-banking-releve-dividende-3-pourcent-038-dollar</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:11:31.232Z</news:publication_date>
      <news:title>Columbia Banking relève son dividende de 3% à 0,38 $ par action</news:title>
      <news:keywords>columbia-banking, colb-dividend, regional-banks, dividend-increase, share-buyback</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/哥伦比亚银行股息上调3</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:11:31.232Z</news:publication_date>
      <news:title>哥伦比亚银行将股息上调3%至每股0.38美元</news:title>
      <news:keywords>columbia-banking, colb-dividend, regional-banks, dividend-increase, share-buyback</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/columbia-banking-sube-dividendo-3-por-ciento-recompra-1200-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:11:31.232Z</news:publication_date>
      <news:title>Columbia Banking sube el dividendo un 3% a 0,38 dólares por acción</news:title>
      <news:keywords>columbia-banking, colb-dividend, regional-banks, dividend-increase, share-buyback</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/columbia-banking-alza-dividendo-3percento-038-dollari</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:11:31.232Z</news:publication_date>
      <news:title>Columbia Banking alza il dividendo del 3% a 0,38 dollari per azione</news:title>
      <news:keywords>columbia-banking, colb-dividend, regional-banks, dividend-increase, share-buyback</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/columbia-banking-colb-dividend-increase-038-share-december-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:11:31.231Z</news:publication_date>
      <news:title>Columbia Banking Raises Dividend 3% to $0.38 a Share</news:title>
      <news:keywords>columbia-banking, colb-dividend, regional-banks, dividend-increase, share-buyback</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/keycorp赎回e系列优先股</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:00:23.472Z</news:publication_date>
      <news:title>KeyCorp将于12月15日赎回5亿美元E系列优先股</news:title>
      <news:keywords>keycorp, preferred-stock, series-e-preferred, bank-capital, nyse-key</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/keycorp-amortiza-500-millones-preferentes-serie-e-15-diciembre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:00:23.471Z</news:publication_date>
      <news:title>KeyCorp amortiza 500 M$ de preferentes Serie E el 15 de diciembre</news:title>
      <news:keywords>keycorp, preferred-stock, series-e-preferred, bank-capital, nyse-key</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/keycorp-rachat-500-millions-preference-serie-e-15-decembre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:00:23.471Z</news:publication_date>
      <news:title>KeyCorp rachète 500 M$ de préférence série E le 15 déc.</news:title>
      <news:keywords>keycorp, preferred-stock, series-e-preferred, bank-capital, nyse-key</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/keycorp-rimborso-500-milioni-preferred-serie-e-15-dicembre</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:00:23.471Z</news:publication_date>
      <news:title>KeyCorp rimborsa 500 mln $ di privilegiate Serie E il 15 dicembre</news:title>
      <news:keywords>keycorp, preferred-stock, series-e-preferred, bank-capital, nyse-key</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/keycorp-redeems-500m-series-e-preferred-stock-december-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T12:00:23.471Z</news:publication_date>
      <news:title>KeyCorp Redeems $500M Series E Preferred on Dec 15</news:title>
      <news:keywords>keycorp, preferred-stock, series-e-preferred, bank-capital, nyse-key</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/calidi第三季度净亏损收窄</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:54:19.167Z</news:publication_date>
      <news:title>Calidi Biotherapeutics 2026年第三季度净亏损收窄至360万美元</news:title>
      <news:keywords>calidi-biotherapeutics, cldi-stock, cld-401, oncolytic-virus, biotech-financials</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/calidi-biotherapeutics-perdita-netta-3-6-milioni-q3-2026-cld-401</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:54:19.166Z</news:publication_date>
      <news:title>Calidi Biotherapeutics riduce la perdita netta a 3,6 mln nel Q3 2026</news:title>
      <news:keywords>calidi-biotherapeutics, cldi-stock, cld-401, oncolytic-virus, biotech-financials</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/calidi-biotherapeutics-reduce-perdida-neta-3-6-millones-t3-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:54:19.166Z</news:publication_date>
      <news:title>Calidi Biotherapeutics reduce su pérdida neta a 3,6 M$ en el T3 2026</news:title>
      <news:keywords>calidi-biotherapeutics, cldi-stock, cld-401, oncolytic-virus, biotech-financials</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/calidi-biotherapeutics-perte-nette-t3-2026-cld-401-financement</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:54:19.166Z</news:publication_date>
      <news:title>Calidi Biotherapeutics réduit sa perte nette à 3,6 M$ au T3 2026</news:title>
      <news:keywords>calidi-biotherapeutics, cldi-stock, cld-401, oncolytic-virus, biotech-financials</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/calidi-biotherapeutics-q3-2026-net-loss-cld-401-cash-runway</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:54:19.165Z</news:publication_date>
      <news:title>Calidi Biotherapeutics Cuts Net Loss to $3.6M in Q3 2026</news:title>
      <news:keywords>calidi-biotherapeutics, cldi-stock, cld-401, oncolytic-virus, biotech-financials</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/air-t-ingresos-129-rex-perdidas-antes-impuestos</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:48:14.454Z</news:publication_date>
      <news:title>Air T dispara sus ingresos un 129% hasta 146,9 M$ y entra en pérdidas antes de impuestos de 16,2 M$</news:title>
      <news:keywords>air-t-inc, airt-stock, regional-express-rex, aviation-leasing, ground-support-equipment</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/airt营收飙升129-转亏</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:48:14.454Z</news:publication_date>
      <news:title>Air T营收飙升129%至1.469亿美元，转为税前亏损1620万美元</news:title>
      <news:keywords>air-t-inc, airt-stock, regional-express-rex, aviation-leasing, ground-support-equipment</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/air-t-chiffre-affaires-129-pourcent-perte-avant-impots-rex</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:48:14.454Z</news:publication_date>
      <news:title>Air T : le chiffre d&apos;affaires bondit de 129% à 146,9 M$, perte avant impôts de 16,2 M$</news:title>
      <news:keywords>air-t-inc, airt-stock, regional-express-rex, aviation-leasing, ground-support-equipment</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/air-t-ricavi-129-acquisizione-rex-perdita-pre-imposte</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:48:14.453Z</news:publication_date>
      <news:title>Ricavi Air T +129% a 146,9 mln, perdita pre-imposte di 16,2 mln</news:title>
      <news:keywords>air-t-inc, airt-stock, regional-express-rex, aviation-leasing, ground-support-equipment</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/air-t-q2-fiscal-2027-revenue-146-9m-pretax-loss-rex</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:48:14.453Z</news:publication_date>
      <news:title>Air T Revenue Jumps 129% to $146.9M, Swings to $16.2M Pre-Tax Loss</news:title>
      <news:keywords>air-t-inc, airt-stock, regional-express-rex, aviation-leasing, ground-support-equipment</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/air-t-ingresos-t2-129-por-ciento-rex-ebitda-ajustado</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:42:04.914Z</news:publication_date>
      <news:title>Air T dispara sus ingresos del T2 un 129% hasta 146,9 M$ por Rex</news:title>
      <news:keywords>air-t-inc, airt-stock, regional-express-rex, aviation-equities, q2-fy27-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/airt收购rex营收翻倍</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:42:04.914Z</news:publication_date>
      <news:title>Air T第二季度营收因Rex交易飙升129%至1.469亿美元</news:title>
      <news:keywords>air-t-inc, airt-stock, regional-express-rex, aviation-equities, q2-fy27-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/air-t-chiffre-affaires-t2-bondit-129-pourcent-rex</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:42:04.914Z</news:publication_date>
      <news:title>Air T : le chiffre d&apos;affaires du T2 bondit de 129% à 146,9 M$</news:title>
      <news:keywords>air-t-inc, airt-stock, regional-express-rex, aviation-equities, q2-fy27-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/air-t-q2-fy27-revenue-146-9m-rex-acquisition-ebitda-falls</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:42:04.913Z</news:publication_date>
      <news:title>Air T Q2 Revenue Jumps 129% to $146.9M on Rex Deal</news:title>
      <news:keywords>air-t-inc, airt-stock, regional-express-rex, aviation-equities, q2-fy27-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/air-t-ricavi-q2-fy27-crescita-129-acquisizione-rex</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:42:04.913Z</news:publication_date>
      <news:title>Air T, ricavi Q2 +129% a 146,9 milioni con Rex</news:title>
      <news:keywords>air-t-inc, airt-stock, regional-express-rex, aviation-equities, q2-fy27-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/黄金3927失败周跌4-7</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:30:54.600Z</news:publication_date>
      <news:title>黄金期货冲击3927美元失败，周线收跌4.7%</news:title>
      <news:keywords>gold-futures, comex-gold, gold-price-levels, precious-metals, gold-support-3879</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/futuros-oro-fallan-3927-cierran-semana-caida-47-por-ciento</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:30:54.598Z</news:publication_date>
      <news:title>Los futuros del oro fallan en 3.927 $ y cierran la semana con una caída del 4,7%</news:title>
      <news:keywords>gold-futures, comex-gold, gold-price-levels, precious-metals, gold-support-3879</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/or-echec-rallye-3927-cloture-semaine-baisse-47-pourcent</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:30:54.598Z</news:publication_date>
      <news:title>L&apos;or échoue à 3 927 $ et clôture la semaine en baisse de 4,7 %</news:title>
      <news:keywords>gold-futures, comex-gold, gold-price-levels, precious-metals, gold-support-3879</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/future-oro-falliscono-3927-chiusura-settimanale-calo-47</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:30:54.597Z</news:publication_date>
      <news:title>I future sull&apos;oro falliscono a $3.927, settimana in calo del 4,7%</news:title>
      <news:keywords>gold-futures, comex-gold, gold-price-levels, precious-metals, gold-support-3879</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/gold-futures-fail-rally-close-week-down-3879-support</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T11:30:54.597Z</news:publication_date>
      <news:title>Gold Futures Fail at $3,927, Close Week Down 4.7%</news:title>
      <news:keywords>gold-futures, comex-gold, gold-price-levels, precious-metals, gold-support-3879</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/nextplat-ingresos-q3-caen-margen-bruto-sube-perdidas-bajan</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:37:47.587Z</news:publication_date>
      <news:title>NextPlat reduce pérdidas un 66% pese a caer a 10,5M$</news:title>
      <news:keywords>nextplat, nxpl, pharmacy-340b, healthcare-stocks, quarterly-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/nextplat-nxpl-340b毛利率</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:37:47.587Z</news:publication_date>
      <news:title>NextPlat第三季度营收降至1050万美元，净亏损收窄66%</news:title>
      <news:keywords>nextplat, nxpl, pharmacy-340b, healthcare-stocks, quarterly-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/nextplat-t3-revenus-10-5-m-perte-nette-reduite-66-pourcent</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:37:47.587Z</news:publication_date>
      <news:title>NextPlat T3 : revenus à 10,5 M$, perte nette -66 %</news:title>
      <news:keywords>nextplat, nxpl, pharmacy-340b, healthcare-stocks, quarterly-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/nextplat-ricavi-q3-10-5-milioni-perdita-netta-giu-66</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:37:47.586Z</news:publication_date>
      <news:title>NextPlat: ricavi Q3 a 10,5 mln, perdita netta -66%</news:title>
      <news:keywords>nextplat, nxpl, pharmacy-340b, healthcare-stocks, quarterly-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/nextplat-q3-2026-revenue-10-5m-net-loss-cuts-66-percent-nxpl</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:37:47.586Z</news:publication_date>
      <news:title>NextPlat Q3 Revenue Falls to $10.5M, Net Loss Cut 66%</news:title>
      <news:keywords>nextplat, nxpl, pharmacy-340b, healthcare-stocks, quarterly-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/femasys-ingresos-q3-caen-445-tras-ronda-30-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:36:38.407Z</news:publication_date>
      <news:title>Femasys cae un 44,5% en el tercer trimestre tras captar 30 millones</news:title>
      <news:keywords>femasys, femy-stock, fema-seed, fem-blocc, medical-devices</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/femasys第三季度营收降44-5</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:36:38.407Z</news:publication_date>
      <news:title>Femasys第三季度营收下降44.5%，此前完成3000万美元融资</news:title>
      <news:keywords>femasys, femy-stock, fema-seed, fem-blocc, medical-devices</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/femasys-chiffre-affaires-t3-chute-levee-30-millions</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:36:38.406Z</news:publication_date>
      <news:title>Femasys : le chiffre d&apos;affaires du T3 chute de 44,5 % après une levée de 30 M$</news:title>
      <news:keywords>femasys, femy-stock, fema-seed, fem-blocc, medical-devices</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/femasys-ricavi-q3-calo-44-5-dopo-aumento-capitale-30-milioni</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:36:38.405Z</news:publication_date>
      <news:title>Femasys: ricavi Q3 -44,5% dopo aumento da 30 mln $</news:title>
      <news:keywords>femasys, femy-stock, fema-seed, fem-blocc, medical-devices</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/femasys-q3-2026-revenue-falls-30m-private-placement-femy</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:36:38.405Z</news:publication_date>
      <news:title>Femasys Q3 Revenue Falls 44.5% After $30M Raise</news:title>
      <news:keywords>femasys, femy-stock, fema-seed, fem-blocc, medical-devices</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/american-strategic-perte-6-7-millions-revenus-divises-par-deux</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:30:19.844Z</news:publication_date>
      <news:title>Perte d&apos;American Strategic élargie à 6,7 M$ et revenus divisés par deux</news:title>
      <news:keywords>american-strategic-investment, nyse-nyc, commercial-real-estate, new-york-city-office, reit-alternative</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/american-strategic-investment-q3-2026-net-loss-revenue-drop</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:30:19.844Z</news:publication_date>
      <news:title>American Strategic Loss Widens to $6.7M as Revenue Halves</news:title>
      <news:keywords>american-strategic-investment, nyse-nyc, commercial-real-estate, new-york-city-office, reit-alternative</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/american-strategic-perdita-6-7-milioni-ricavi-dimezzati</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:30:19.844Z</news:publication_date>
      <news:title>Perdita di American Strategic sale a 6,7 mln, ricavi dimezzati</news:title>
      <news:keywords>american-strategic-investment, nyse-nyc, commercial-real-estate, new-york-city-office, reit-alternative</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/美国战略投资670万亏损</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:30:19.844Z</news:publication_date>
      <news:title>美国战略投资净亏损扩大至670万美元，营收腰斩</news:title>
      <news:keywords>american-strategic-investment, nyse-nyc, commercial-real-estate, new-york-city-office, reit-alternative</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/american-strategic-investment-perdida-6-7-millones-ingresos-mitad</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:30:19.844Z</news:publication_date>
      <news:title>La pérdida estratégica de American se amplía a 6,7 M$ mientras los ingresos se reducen a la mitad</news:title>
      <news:keywords>american-strategic-investment, nyse-nyc, commercial-real-estate, new-york-city-office, reit-alternative</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/cerenome-q3-2026-ingresos-cnside-caja-desciende</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:18:56.793Z</news:publication_date>
      <news:title>Cerenome Q3 2026: ingresos de CNSide 0,7 M$ y caja de 4,9 M$</news:title>
      <news:keywords>cerenome, cnsy, cnside, leptomeningeal-metastases, cns-oncology</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/cerenome-cnside收入70万</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:18:56.793Z</news:publication_date>
      <news:title>Cerenome 2026年第三季度：CNSide收入达70万美元，现金降至490万美元</news:title>
      <news:keywords>cerenome, cnsy, cnside, leptomeningeal-metastases, cns-oncology</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/cerenome-t3-2026-revenus-cnside-tresorerie-chute</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:18:56.793Z</news:publication_date>
      <news:title>Cerenome T3 2026 : revenus CNSide à 0,7 M$, trésorerie à 4,9 M$</news:title>
      <news:keywords>cerenome, cnsy, cnside, leptomeningeal-metastases, cns-oncology</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/cerenome-q3-2026-ricavi-cnside-07-mln-liquidita-49-mln</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:18:56.791Z</news:publication_date>
      <news:title>Cerenome Q3 2026: ricavi CNSide a 0,7 M$, liquidità a 4,9 M$</news:title>
      <news:keywords>cerenome, cnsy, cnside, leptomeningeal-metastases, cns-oncology</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/cerenome-q3-2026-cnside-diagnostic-revenue-cash-position-cnsy</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:18:56.791Z</news:publication_date>
      <news:title>Cerenome Q3 2026: CNSide Revenue Hits $0.7M, Cash Falls to $4.9M</news:title>
      <news:keywords>cerenome, cnsy, cnside, leptomeningeal-metastases, cns-oncology</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/seritage-utile-q3-2026-riduzione-debito-piano-vendita</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:12:48.114Z</news:publication_date>
      <news:title>Seritage chiude il Q3 con 2,7 mln di utile e debito a 29,5 mln</news:title>
      <news:keywords>seritage-growth-properties, SRG, REIT earnings, plan of sale, commercial real estate</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/seritage三季度扭亏为盈</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:12:48.114Z</news:publication_date>
      <news:title>Seritage第三季度盈利270万美元，债务降至2950万美元</news:title>
      <news:keywords>seritage-growth-properties, SRG, REIT earnings, plan of sale, commercial real estate</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/seritage-gana-27-millones-t3-reduce-deuda-295-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:12:48.114Z</news:publication_date>
      <news:title>Seritage gana 2,7 M$ en el T3 y reduce su deuda a 29,5 M$</news:title>
      <news:keywords>seritage-growth-properties, SRG, REIT earnings, plan of sale, commercial real estate</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/seritage-benefice-t3-reduction-dette-plan-de-vente</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:12:48.114Z</news:publication_date>
      <news:title>Seritage affiche 2,7 M$ de bénéfice au T3 et réduit sa dette à 29,5 M$</news:title>
      <news:keywords>seritage-growth-properties, SRG, REIT earnings, plan of sale, commercial real estate</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/seritage-growth-properties-q3-2026-net-income-debt-reduction</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T00:12:48.113Z</news:publication_date>
      <news:title>Seritage Posts $2.7M Q3 Profit, Cuts Debt to $29.5M</news:title>
      <news:keywords>seritage-growth-properties, SRG, REIT earnings, plan of sale, commercial real estate</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/evofem-beneficio-0-9-millones-ventas-phexx-caen-4-6-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:56:22.821Z</news:publication_date>
      <news:title>Evofem logra 0,9 M$ de beneficio con ventas de PHEXX de 4,6 M$</news:title>
      <news:keywords>evofem-biosciences, evfm-stock, phexx-sales, solosec, pharma-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/evofem扭亏phexx销售下滑</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:56:22.821Z</news:publication_date>
      <news:title>Evofem扭亏为盈赚90万美元 PHEXX销售降至460万</news:title>
      <news:keywords>evofem-biosciences, evfm-stock, phexx-sales, solosec, pharma-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/evofem-benefice-0-9-m-ventes-phexx-4-6-m-t3-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:56:22.821Z</news:publication_date>
      <news:title>Evofem renoue avec un bénéfice de 0,9 M$ malgré des ventes PHEXX à 4,6 M$</news:title>
      <news:keywords>evofem-biosciences, evfm-stock, phexx-sales, solosec, pharma-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/evofem-utile-0-9-mln-vendite-phexx-4-6-mln-q3-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:56:22.820Z</news:publication_date>
      <news:title>Evofem torna all&apos;utile con 0,9 mln di dollari, vendite PHEXX a 4,6 mln</news:title>
      <news:keywords>evofem-biosciences, evfm-stock, phexx-sales, solosec, pharma-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/evofem-q3-2026-profit-phexx-sales-fall-solosec</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:56:22.820Z</news:publication_date>
      <news:title>Evofem Swings to $0.9M Profit as PHEXX Sales Fall to $4.6M</news:title>
      <news:keywords>evofem-biosciences, evfm-stock, phexx-sales, solosec, pharma-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/health-in-tech-perdita-q3-2026-ricavi-in-calo-pipeline</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:45:04.221Z</news:publication_date>
      <news:title>Health In Tech, perdita Q3 sale a 7,1 milioni di dollari</news:title>
      <news:keywords>health-in-tech, hit-stock, insurtech-earnings, q3-2026-results, stop-loss-insurance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/health-in-tech-q3亏损扩大</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:45:04.221Z</news:publication_date>
      <news:title>Health In Tech 2026年Q3亏损扩大至710万美元，营收下滑</news:title>
      <news:keywords>health-in-tech, hit-stock, insurtech-earnings, q3-2026-results, stop-loss-insurance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/health-in-tech-perdidas-t3-2026-caida-ingresos-pipeline</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:45:04.221Z</news:publication_date>
      <news:title>Health In Tech amplía pérdidas a 7,1 M$ en el T3 con caída de ingresos</news:title>
      <news:keywords>health-in-tech, hit-stock, insurtech-earnings, q3-2026-results, stop-loss-insurance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/health-in-tech-perte-t3-2026-revenus-baisse-pipeline</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:45:04.221Z</news:publication_date>
      <news:title>Health In Tech : perte de 7,1 M$ au T3, revenus en baisse</news:title>
      <news:keywords>health-in-tech, hit-stock, insurtech-earnings, q3-2026-results, stop-loss-insurance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/health-in-tech-q3-2026-net-loss-revenue-decline-hit</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:45:04.220Z</news:publication_date>
      <news:title>Health In Tech Q3 Loss Widens to $7.1M as Revenue Slips</news:title>
      <news:keywords>health-in-tech, hit-stock, insurtech-earnings, q3-2026-results, stop-loss-insurance</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/where-food-comes-from-ca-t3-en-hausse-resultat-operationnel-en-bond</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:38:59.733Z</news:publication_date>
      <news:title>Where Food Comes From : CA T3 +4%, résultat opérationnel +68%</news:title>
      <news:keywords>where-food-comes-from, wfcf-stock, food-verification, third-quarter-earnings, beef-industry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/wfcf第三季度营收增4</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:38:59.733Z</news:publication_date>
      <news:title>Where Food Comes From第三季度营收增长4%，营业利润跃升68%</news:title>
      <news:keywords>where-food-comes-from, wfcf-stock, food-verification, third-quarter-earnings, beef-industry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/where-food-comes-from-ingresos-t3-beneficio-operativo-68</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:38:59.733Z</news:publication_date>
      <news:title>Where Food Comes From: ingresos del T3 suben 4%, beneficio operativo +68%</news:title>
      <news:keywords>where-food-comes-from, wfcf-stock, food-verification, third-quarter-earnings, beef-industry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/where-food-comes-from-ricavi-q3-4-utile-operativo-68</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:38:59.732Z</news:publication_date>
      <news:title>Where Food Comes From: ricavi Q3 +4%, utile operativo +68%</news:title>
      <news:keywords>where-food-comes-from, wfcf-stock, food-verification, third-quarter-earnings, beef-industry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/where-food-comes-from-q3-2026-revenue-operating-income-jumps</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:38:59.732Z</news:publication_date>
      <news:title>Where Food Comes From Q3 Revenue Up 4%, Operating Income Jumps 68%</news:title>
      <news:keywords>where-food-comes-from, wfcf-stock, food-verification, third-quarter-earnings, beef-industry</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/ctnt营收暴涨883</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:37:49.572Z</news:publication_date>
      <news:title>Cheetah Net第三季度营收因Super International交易暴涨883%</news:title>
      <news:keywords>cheetah-net, ctnt-stock, international-trading, logistics-warehousing, microcap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/cheetah-net-ingresos-t3-suben-883-super-international</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:37:49.572Z</news:publication_date>
      <news:title>Ingresos de Cheetah Net en el T3 suben 883% por el acuerdo con Super International</news:title>
      <news:keywords>cheetah-net, ctnt-stock, international-trading, logistics-warehousing, microcap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/cheetah-net-ricavi-q3-2026-crescita-883-super-international</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:37:49.571Z</news:publication_date>
      <news:title>Cheetah Net: ricavi Q3 +883% grazie a Super International</news:title>
      <news:keywords>cheetah-net, ctnt-stock, international-trading, logistics-warehousing, microcap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/cheetah-net-chiffre-affaires-t3-bondit-883-super-international</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:37:49.571Z</news:publication_date>
      <news:title>Cheetah Net : le chiffre d&apos;affaires du T3 bondit de 883 % grâce à Super International</news:title>
      <news:keywords>cheetah-net, ctnt-stock, international-trading, logistics-warehousing, microcap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/cheetah-net-ctnt-q3-2026-revenue-883-percent-super-international-trading</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:37:49.570Z</news:publication_date>
      <news:title>Cheetah Net Q3 Revenue Jumps 883% on Super International Deal</news:title>
      <news:keywords>cheetah-net, ctnt-stock, international-trading, logistics-warehousing, microcap-earnings</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/cingulate-nda-重新提交-现金2320万</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:21:23.541Z</news:publication_date>
      <news:title>Cingulate 的 NDA 重新提交定于 2026 年 12 月，现金达 2320 万美元</news:title>
      <news:keywords>cingulate, ctx-1301, adhd-drug-nda, fda-complete-response-letter, biopharma-cash-runway</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/cingulate-nda-ctx-1301-ripresentazione-2026-liquidita</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:21:23.540Z</news:publication_date>
      <news:title>Cingulate, NDA ripresentata a dic 2026 con 23,2 mln di dollari</news:title>
      <news:keywords>cingulate, ctx-1301, adhd-drug-nda, fda-complete-response-letter, biopharma-cash-runway</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/cingulate-reenvio-nda-diciembre-2026-caja-23-millones</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:21:23.540Z</news:publication_date>
      <news:title>Cingulate reprograma el reenvío de la NDA para dic 2026 con 23,2 M$ en caja</news:title>
      <news:keywords>cingulate, ctx-1301, adhd-drug-nda, fda-complete-response-letter, biopharma-cash-runway</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/cingulate-nda-ctx-1301-refiling-decembre-2026-tresorerie</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:21:23.540Z</news:publication_date>
      <news:title>Cingulate repousse sa NDA à déc. 2026, trésorerie à 23,2 M$</news:title>
      <news:keywords>cingulate, ctx-1301, adhd-drug-nda, fda-complete-response-letter, biopharma-cash-runway</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/cingulate-ctx-1301-nda-resubmission-cash-q3-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T23:21:23.539Z</news:publication_date>
      <news:title>Cingulate NDA Resubmit Set for Dec 2026 as Cash Hits $23.2M</news:title>
      <news:keywords>cingulate, ctx-1301, adhd-drug-nda, fda-complete-response-letter, biopharma-cash-runway</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/ionq-nombra-cfo-gary-merrill-sale-inder-singh</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:44:38.119Z</news:publication_date>
      <news:title>IonQ nombra a Gary Merrill director financiero y sale Inder Singh</news:title>
      <news:keywords>ionq, quantum-computing, executive-leadership, cfo-appointment, nyse-ionq</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/ionq任命gary-merrill为cfo</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:44:38.119Z</news:publication_date>
      <news:title>IonQ任命Gary Merrill为CFO，Inder Singh即刻离任</news:title>
      <news:keywords>ionq, quantum-computing, executive-leadership, cfo-appointment, nyse-ionq</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/ionq-nomme-gary-merrill-directeur-financier-inder-singh-quitte</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:44:38.119Z</news:publication_date>
      <news:title>IonQ nomme Gary Merrill directeur financier, Inder Singh quitte</news:title>
      <news:keywords>ionq, quantum-computing, executive-leadership, cfo-appointment, nyse-ionq</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/ionq-nomina-gary-merrill-cfo-uscita-inder-singh</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:44:38.118Z</news:publication_date>
      <news:title>IonQ nomina Gary Merrill CFO mentre Inder Singh esce</news:title>
      <news:keywords>ionq, quantum-computing, executive-leadership, cfo-appointment, nyse-ionq</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/ionq-gary-merrill-cfo-thomas-austin-cao-singh-exits</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:44:38.118Z</news:publication_date>
      <news:title>IonQ Names Gary Merrill CFO as Inder Singh Exits</news:title>
      <news:keywords>ionq, quantum-computing, executive-leadership, cfo-appointment, nyse-ionq</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/bcic净投资收益净资产值下降</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:33:20.939Z</news:publication_date>
      <news:title>BCP投资公司每股净投资收益0.37美元，净资产值降至13.13美元</news:title>
      <news:keywords>bcp-investment-corp, bcic, bdc-merger, icmb-acquisition, net-asset-value</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/bcp-investment-corp-nii-037-nav-1313-fusion-investcorp-bdc</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:33:20.939Z</news:publication_date>
      <news:title>BCP Investment Corp registra NII de $0,37 y su NAV cae a $13,13</news:title>
      <news:keywords>bcp-investment-corp, bcic, bdc-merger, icmb-acquisition, net-asset-value</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/bcp-investment-corp-nii-037-vni-1313-acquisition-investcorp</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:33:20.939Z</news:publication_date>
      <news:title>BCP Investment Corp : NII de 0,37 $, la VNI chute à 13,13 $</news:title>
      <news:keywords>bcp-investment-corp, bcic, bdc-merger, icmb-acquisition, net-asset-value</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/bcp-investment-corp-nii-037-nav-1313-acquisizione-investcorp</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:33:20.939Z</news:publication_date>
      <news:title>BCP Investment Corp: NII a $0,37, NAV scende a $13,13</news:title>
      <news:keywords>bcp-investment-corp, bcic, bdc-merger, icmb-acquisition, net-asset-value</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/bcp-investment-corp-q3-2026-nii-nav-drop-icmb-merger</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:33:20.939Z</news:publication_date>
      <news:title>BCP Investment Corp Posts $0.37 NII, NAV Falls to $13.13</news:title>
      <news:keywords>bcp-investment-corp, bcic, bdc-merger, icmb-acquisition, net-asset-value</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/beyondspring-plinabulin-fda快速通道</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:32:15.546Z</news:publication_date>
      <news:title>BeyondSpring获FDA快速通道资格：Plinabulin治疗NSCLC</news:title>
      <news:keywords>beyondspring, bysi, plinabulin, dublin-4, fda-fast-track, non-small-cell-lung-cancer</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/beyondspring-via-rapida-fda-plinabulin-nsclc-post-ici</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:32:15.546Z</news:publication_date>
      <news:title>BeyondSpring logra vía rápida de la FDA para Plinabulin en NSCLC</news:title>
      <news:keywords>beyondspring, bysi, plinabulin, dublin-4, fda-fast-track, non-small-cell-lung-cancer</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/beyondspring-fast-track-fda-plinabulin-cbnpc-post-ici</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:32:15.546Z</news:publication_date>
      <news:title>BeyondSpring obtient le statut Fast Track de la FDA pour le Plinabulin dans le CBNPC</news:title>
      <news:keywords>beyondspring, bysi, plinabulin, dublin-4, fda-fast-track, non-small-cell-lung-cancer</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/beyondspring-fast-track-fda-plinabulin-nsclc-post-ici</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:32:15.545Z</news:publication_date>
      <news:title>BeyondSpring ottiene Fast Track FDA per Plinabulin nel NSCLC</news:title>
      <news:keywords>beyondspring, bysi, plinabulin, dublin-4, fda-fast-track, non-small-cell-lung-cancer</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/beyondspring-fda-fast-track-plinabulin-dublin-4-nsclc-q3-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:32:15.544Z</news:publication_date>
      <news:title>BeyondSpring Wins FDA Fast Track for Plinabulin in NSCLC</news:title>
      <news:keywords>beyondspring, bysi, plinabulin, dublin-4, fda-fast-track, non-small-cell-lung-cancer</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/zh/tempest-tpst-现金危机</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>zh</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:31:08.861Z</news:publication_date>
      <news:title>Tempest Therapeutics第三季度亏损360万美元，现金降至89.7万美元</news:title>
      <news:keywords>tempest-therapeutics, tpst-stock, in-vivo-car-t, biotech-earnings, going-concern</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/es/tempest-therapeutics-perdida-q3-caja-897000-aviso-empresa-en-marcha</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>es</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:31:08.860Z</news:publication_date>
      <news:title>Tempest Therapeutics pierde 3,6 M$ en el Q3 y su caja cae a 897.000 $</news:title>
      <news:keywords>tempest-therapeutics, tpst-stock, in-vivo-car-t, biotech-earnings, going-concern</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/fr/tempest-therapeutics-perte-t3-tresorerie-897k-avertissement-continuite</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>fr</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:31:08.860Z</news:publication_date>
      <news:title>Tempest Therapeutics : perte de 3,6 M$ au T3, trésorerie à 897 K$</news:title>
      <news:keywords>tempest-therapeutics, tpst-stock, in-vivo-car-t, biotech-earnings, going-concern</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/it/tempest-therapeutics-perdita-q3-liquidita-897000-continuita-aziendale</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>it</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:31:08.860Z</news:publication_date>
      <news:title>Tempest Therapeutics: perdita Q3 di 3,6 milioni, liquidità a 897.000 dollari</news:title>
      <news:keywords>tempest-therapeutics, tpst-stock, in-vivo-car-t, biotech-earnings, going-concern</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://fazen.markets/en/tempest-therapeutics-q3-2026-loss-cash-going-concern</loc>
    <news:news>
      <news:publication>
        <news:name>Fazen Markets</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13T22:31:08.859Z</news:publication_date>
      <news:title>Tempest Therapeutics Q3 Loss Hits $3.6M as Cash Falls to $897K</news:title>
      <news:keywords>tempest-therapeutics, tpst-stock, in-vivo-car-t, biotech-earnings, going-concern</news:keywords>
    </news:news>
  </url>
</urlset>